Management of Osteoporosis after Transplantation

New Orleans, LA US
February 6, 2020

This presentation will focus on presenting evidence-based information regarding the epidemiology, pathophysiology, diagnosis, assessment, pharmacological management and monitoring of patients with, or at risk for post-transplant osteoporosis. Exposure to this specific population of transplant patients may differ between pharmacists, but it is necessary that all pharmacists understand how to manage this disease state, as a variety of patient populations can be affected by glucocorticoid-induced bone disease. This presentation will incorporate interactive learning questions and case-based application questions to engage pharmacists in an active learning method.

Target Audience

  • Pharmacists
  • Pharmacy technicians

 

Learning Objectives

Pharmacist learning objectives

  1. Describe the risk factors for and diagnosis of patients with post-transplant osteoporosis
  2. Analyze the literature supporting the use of pharmacologic agents in prevention and treatment of post-transplant osteoporosis
  3. Design a therapeutic regimen including non-pharmacological and pharmacological modalities for management of post-transplant osteoporosis

Pharmacy technician learning objectives

  1. Identify the pharmacological options for the management of post-transplant osteoporosis
  2. Recognize the dosage forms of the medications used for management of post-transplant osteoporosis
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance
Course opens: 
02/06/2020
Course expires: 
03/22/2020
Event starts: 
02/06/2020 - 12:00pm
Event ends: 
02/06/2020 - 1:00pm
Cost:
$0.00
Ochsner Medical Center
1514 Jefferson Hwy.
New Orleans, LA 70121
United States
Relevant financial relationships: Planning committee and the presenter have nothing to disclose
Planning committee members
Julie Mandel, PharmD
PGY2 Solid Organ Transplant Pharmacy Resident
Ochsner Medical Center
 
Stephanie Anders, PharmD, BCPS
Clinical Pharmacist, Solid Organ Transplant
Ochsner Medical Center
 
Course reviewer
Katrina Harper, PharmD, MBA, BCPS, BCSCP
Clinical Pharmacy Director
Vizient
 
Presenter
Julie Mandel, PharmD
PGY2 Solid Organ Transplant Pharmacy Resident
Ochsner Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-032-L01-P
Universal Activity Number: JA0006103-9999-20-032-L01-T
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.